Town Square

Post a New Topic

FDA advisory panel recommends emergency use approval of Novavax COVID vaccine

Original post made on Jun 13, 2022

An advisory panel to the U.S. Food and Drug Administration voted last week to recommend an emergency use authorization for the COVID-19 vaccine developed by the Maryland-based biotechnology company Novavax.

Read the full story here Web Link posted Sunday, June 12, 2022, 4:31 PM

Comments (1)

Posted by Parent and Voter
a resident of Danville
on Jun 13, 2022 at 6:49 am

Parent and Voter is a registered user.

While I had gotten the earlier Moderna vaccine I personally would have liked the option of an alternative of a more traditional version vaccine such as the one Novavax offers. It would be helpful to get more details about the trial results so that everything is transparent.

Don't miss out on the discussion!
Sign up to be notified of new comments on this topic.


Post a comment

In order to encourage respectful and thoughtful discussion, commenting on stories is available to those who are registered users. If you are already a registered user and the commenting form is not below, you need to log in. If you are not registered, you can do so here.

Please make sure your comments are truthful, on-topic and do not disrespect another poster. Don't be snarky or belittling. All postings are subject to our TERMS OF USE, and may be deleted if deemed inappropriate by our staff.

See our announcement about requiring registration for commenting.

Stay informed.

Get the day's top headlines from sent to your inbox in the Express newsletter.

E-Bikes on Open Space Trails: Yes or No?
By Sherry Listgarten | 11 comments | 3,625 views

Gifts and Belongings
By Chandrama Anderson | 2 comments | 1,701 views

Tri-Valley lost key leader when Rich Rankin died
By Tim Hunt | 4 comments | 1,203 views

Does Applying to More Highly Selective Schools Increase Your Chance of Getting Admitted?
By Elizabeth LaScala | 0 comments | 1,095 views

Bored Games
By Monith Ilavarasan | 0 comments | 767 views